The role of Hippo signal pathway in breast cancer metastasis

References

• AltobelliERapacchiettaLAngelettiPBreast cancer screening programmes across the WHO European region: differences among countries based on national income levelInt J Environ Res Public Health2017144E45228441745
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• GinsburgOBrayFColemanMPThe global burden of women’s cancers: a grand challenge in global healthLancet20163891007184786027814965
   PubMed Web of Science ®Google Scholar
• LiXDangXSunXExpression of survivin and VEGF-C in breast cancer tissue and its relation to lymphatic metastasisEur J Gynaecol Oncol201233217818222611959
   PubMed Web of Science ®Google Scholar
• TalmadgeJEFidlerIJAACR centennial series: the biology of cancer metastasis: historical perspectiveCancer Res201070145649566920610625
   PubMed Web of Science ®Google Scholar
• FuVPlouffeSWGuanKLThe Hippo pathway in organ development, homeostasis, and regenerationCurr Opin Cell Biol20184999107
   Web of Science ®Google Scholar
• MengZMoroishiTGuanKLMechanisms of Hippo pathway regulationGenes Dev201630111726728553
   PubMed Web of Science ®Google Scholar
• JusticeRWZilianOWoodsDFNollMBryantPJThe Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferationGenes Dev1995955345467698644
   PubMed Web of Science ®Google Scholar
• ZhaoBLiLGuanKLHippo signalling at a glanceCell Sci20101232340014006
   PubMed Web of Science ®Google Scholar
• BarryERCamargoFDThe Hippo superhighway: signalling cross roads converging on the Hippo/Yap pathway in stem cells and developmentCurr Opin Cell Biol20132524725323312716
   PubMed Web of Science ®Google Scholar
• VarelasXThe Hippo pathway effectors TAZ and YAP in development, homeostasis and diseaseDevelopment201414181614162624715453
   PubMed Web of Science ®Google Scholar
• YuFXMengZPlouffeSWGuanKLHippo pathway regulation of gastrointestinal tissuesAnnu Rev Physiol20147720122725293527
   PubMed Web of Science ®Google Scholar
• MoroishiTHansenCGGuanKLThe emerging roles of YAP and TAZ in cancerNat Rev Cancer2015152737925592648
   PubMed Web of Science ®Google Scholar
• PiccoloSDupontSCordenonsiMThe biology of YAP/TAZ: hippo signalling and beyondPhysiol Rev20149441287131225287865
   PubMed Web of Science ®Google Scholar
• AtkinsMPotierDRomanelliLAn ectopic network of transcription factors regulated by hippo signaling drives growth and invasion of a malignant tumor modelCurr Biol201626162101211327476594
   PubMed Web of Science ®Google Scholar
• ZhaoBWeiXMLiWQInactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlGenes Dev200721212747276117974916
   PubMed Web of Science ®Google Scholar
• HarveyKTaponNThe Salvador-Warts-Hippo pathway an emerging tumour-suppressor networkNat Rev Cancer20077318219117318211
   PubMed Web of Science ®Google Scholar
• ZhaoBLiLLeiQYGuanKLThe Hippo-YAP pathway in organ size control and tumorigenesis: an updated versionGenes Dev201024986287420439427
   PubMed Web of Science ®Google Scholar
• HoaLKulaberogluYGundogduRThe characterisation of LATS2 kinase regulation in Hippo-YAP signallingCell Signal201628548849726898830
   PubMed Web of Science ®Google Scholar
• LiuCYLvXBLiTTPP1 cooperates with ASPP2 to dephosphorylate and activate TAZJ Biol Chem201128675558556621189257
   PubMed Web of Science ®Google Scholar
• YuFXZhaoBGuanKLHippo pathway in organ size control, tissue homeostasis, and cancerCell2015163481182826544935
   PubMed Web of Science ®Google Scholar
• LiQLiSXMana-CapelliSThe conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in DrosophilaDev Cell201431329130425453828
   PubMed Web of Science ®Google Scholar
• MengZPMoroishiTMottier-PavieVMAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathwayNat Commun20156835726437443
   PubMed Web of Science ®Google Scholar
• ZhengYGWangWLiuBDengHUsterEPanDIdentification of happyhour/MAP4K as alternative Hpo/Mst-like kinases in the hippo kinase cascadeDev Cell201534664265526364751
   PubMed Web of Science ®Google Scholar
• HuangWLvXBLiuCYThe N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibitionJ Biol Chem201228731262452625322692215
   PubMed Web of Science ®Google Scholar
• LeiQYZhangHZhaoBTAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathwayMol Cell Biol20082872426243618227151
   PubMed Web of Science ®Google Scholar
• SchlegelmilchKMohseniMKirakOYAP1 acts downstream of α-catenin to control epidermal proliferationCell2011144578279521376238
   PubMed Web of Science ®Google Scholar
• KimMKimTJohnsonRLLimDSTranscriptional co-repressor function of the hippo pathway transducers YAP and TAZCell Rep201511227028225843714
   PubMed Web of Science ®Google Scholar
• ImajoMMiyatakeKIimuraAMiyamotoANishidaEA molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signallingEMBO J20123151109112222234184
   PubMed Web of Science ®Google Scholar
• FujiiMToyodaTNakanishiHTGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growthJ Exp Med2012209347949422329991
   PubMed Web of Science ®Google Scholar
• UrtasunRLatasaMUDemartisMIConnective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activationHepatology20115462149215821800344
   PubMed Web of Science ®Google Scholar
• BritschgiADussSKimSThe Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαNature2017541763854154528068668
   PubMed Web of Science ®Google Scholar
• ZhouXWangSYWangZEstrogen regulates Hippo signalling via GPERin breast cancerClin Invest2015125521232135
   Google Scholar
• SorrentinoGRuggeriNSpecchiaVMetabolic control of YAP and TAZ by the mevalonate pathwayNat Cell Biol201416435736624658687
   PubMed Web of Science ®Google Scholar
• Van RensbergHJJAzadTLingMThe Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1Cancer Res20187861457147029339539
   PubMed Web of Science ®Google Scholar
• DethlefsenCHansenLSLillelundCExercise-induced catecholamines activate the Hippo tumor suppressor pathway to reduce risks of breast cancer developmentCancer Res201777184894490428887324
   PubMed Web of Science ®Google Scholar
• SorrentinoGRuggeriNZanniniAGlucocorticoid receptor signalling activates YAP in breast cancerNat Commun201781407328102225
   PubMed Web of Science ®Google Scholar
• BosPDZhangXHFNadalCGenes that mediate breast cancer metastasis to the brainNature200945972491005100919421193
   PubMed Web of Science ®Google Scholar
• ChenQZhangNGrayRSA temporal requirement for Hippo signalling in mammary gland differentiation, growth and tumorigenesisGenes Dev201428543243724589775
   PubMed Web of Science ®Google Scholar
• RashidianJLe ScolanEJiXSki regulates Hippo and TAZ signalling to suppress breast cancer progressionSci Signal20158363ra1425670202
   PubMed Web of Science ®Google Scholar
• LiCWangSXingZA ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasisNat Cell Biol201719210611928114269
   PubMed Web of Science ®Google Scholar
• BartucciMDattiloRMoriconiCTAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsOncogene201534668169024531710
   PubMed Web of Science ®Google Scholar
• XiangLGilkesDMHuHHIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cellsOncotarget2015614117681177826059435
   PubMedGoogle Scholar
• BendinelliPMaroniPMatteucciEHypoxia inducible factor-1is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WW domain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancerEur J Cancer201349112608261823566416
   PubMed Web of Science ®Google Scholar
• MaroniPMatteucciEDragoLHypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1 stabilization/nuclear translocation in bone metastasis from breast carcinomaExp Cell Res2015330228729925447306
   PubMed Web of Science ®Google Scholar
• WangJRouseCJasperJSPendergastAMABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signallingSci Signal20169413ra1226838548
   PubMed Web of Science ®Google Scholar
• LaiDHoKCHaoYYangXTaxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGFCancer Res20117172728273821349946
   PubMed Web of Science ®Google Scholar
• LehnSTobinNPSimsAHDecreased expression of YAP is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen responseBMC Cancer20141411924559095
   PubMed Web of Science ®Google Scholar
• Heidary ArashEShibanASongSAttisanoLMARK4 inhibits Hippo signalling to promote proliferation and migration of breast cancer cellsEMBO Rep201718342043628183853
   PubMed Web of Science ®Google Scholar
• HayBAGuoMCoupling cell growth, proliferation, and death. Hippo weighs inDev Cell20035336136312967554
   PubMed Web of Science ®Google Scholar
• VisserSYangXLATS tumor suppressor: a new governor of cellular homeostasisCell Cycle20109193892390320935475
   PubMed Web of Science ®Google Scholar
• CooperJGiancottiFGCancer: a new role for non-canonical Hippo signallingCell Res201727445946028244491
   PubMed Web of Science ®Google Scholar
• LuoX-LLiZ-MYanQEffects of MST1 on cell proliferation and apoptosis of human breast carcinoma cell line MCF-7Tumor20082810852854
   Google Scholar
• OverholtzerMZhangJMSmolenGATransforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconProc Natl Acad Sci U S A200610333124051241016894141
   PubMed Web of Science ®Google Scholar
• SharifGMSchmidtMOYiCCell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signalingOncogene201534485879588925772246
   PubMed Web of Science ®Google Scholar
• LeiQYZhangHZhaoBTAZ promotes cell proliferation and epithelial mesenchymal transition and is inhibited by the hippo pathwayMol Cell Biol20082872426243618227151
   PubMed Web of Science ®Google Scholar
• MiWLinQChildressCGeranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migrationOncogene201534243095310625109332
   PubMed Web of Science ®Google Scholar
• ChanSWLimCJGuoKA role for TAZ in migration, invasion and tumorigenesis of breast cancer cellsCancer Res20086882592259818413727
   PubMed Web of Science ®Google Scholar
• WangYLiuJYingXLinPCZhouBPTwist-mediated epithelial-mesenchymal transition promotes breast tumor cell invasion via inhibition of Hippo pathwaySci Rep201662460627094683
   PubMed Web of Science ®Google Scholar
• WangHDuYCZhouXJLiuHTangSCThe dual functions of YAP-1 to promote and inhibit cell growth in human malignancyCancer Metastasis Rev201433117318224346160
   PubMed Web of Science ®Google Scholar
• YuanMTomlinsonVLaraRYes-associated protein (YAP) functions as a tumor suppressor in breastCell Death Differ200815111752175918617895
   PubMed Web of Science ®Google Scholar
• Jaramillo-RodriguezYCerda-FloresRMRuiz-RamosRYAP expression in normal and neoplastic breast tissue: an immunohistochemical studyArch Med Res201445322322824606817
   PubMed Web of Science ®Google Scholar
• TufailRJordaMZhaoWReisINawazZLoss of yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomasBreast Cancer Res Treat2012313743750
   Web of Science ®Google Scholar
• MatallanasDRomanoDYeeKRASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor proteinMol Cell200727696297517889669
   PubMed Web of Science ®Google Scholar
• WangXDSuLOuQYes-associated protein promotes tumour development in luminal epithelial derived breast cancerEur J Cancer20124881227123422056638
   PubMed Web of Science ®Google Scholar
• KimSKJungWHKooJSYes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancerInt J Clin Exp Pathol201473224323425031743
   PubMed Web of Science ®Google Scholar
• ViciPMottoleseMPizzutiLThe Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapyOncotarget20145209619962525294813
   PubMedGoogle Scholar
• LehnSTobinNPSimsAHDecreased expression of yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen responseBMC Cancer20141411924559095
   PubMed Web of Science ®Google Scholar
• Min KimHKimSKJungWHKooJSMetaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancerTumor Biol201436212071212
   Google Scholar
• Díaz-MartínJLópez-GarcíaMÁRomero-PérezLNuclear TAZ expression associateswith the triple-negative phenotype in breast cancerEndocr Relat Cancer201522344345425870251
   PubMed Web of Science ®Google Scholar
• ErcolaniCDi BenedettoATerrenatoIExpression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapyCancer Biol Ther201718533934628387539
   PubMed Web of Science ®Google Scholar
• Di BenedettoAMottoleseMSperatiFAssociation between AXL, Hippo transducers, and survival outcomes in male breast cancerJ Cell Physiol201723282246225227987320
   PubMed Web of Science ®Google Scholar
• WangCZhuXFengWVerteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasmAm J Cancer Res201561273727073720
   PubMed Web of Science ®Google Scholar
• OkuYNishiyaNShitoTSmall molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancersFEBS Open Bio201551542549
   PubMed Web of Science ®Google Scholar
• JiaoSWangHShiZA peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancerCancer Cell201425216618024525233
   PubMed Web of Science ®Google Scholar
• MoroishiTHayashiTPanWWThe Hippo Pathway Kinases LATS1/2 Suppress Cancer ImmunityCell201616761525.e171539.e1727912060
   PubMed Web of Science ®Google Scholar
• MittendorfEAPhilipsAVMericbernstamFPD-L1 Expression in Triple-Negative Breast CancerCancer Immunol Res20142436137024764583
   PubMed Web of Science ®Google Scholar
• SchmidPCruzCBraitehFSAbstract 2986: atezolizumab in metastatic TNBC (mTNBC): long-term clinical outcomes and biomarker analysesCancer Res20177713 Suppl29862986
   Web of Science ®Google Scholar
• YeSEisinger-MathasonTSTargeting the Hippo pathway: clinical implications and therapeuticsPharmacol Res201510327027826678601
   PubMed Web of Science ®Google Scholar